Roche China Education and Research Fund

Untitleddesign11
With the rapid growth of China's social economy and the ongoing reform of its medical and health systems, public demand for healthcare services continues to rise. High-level medical talent plays a critical role not only in safeguarding people's health but also as a driving force behind the "Healthy China" vision.

As a global leader in diagnostics and pharmaceuticals, Roche leverages its combined expertise to deliver innovative medical solutions. In China, Roche continues to deliver state-of-the-art medical solutions to local patients while actively integrating into the nation’s broader healthcare development strategy, supporting local scientific research and innovation in medicine and life sciences.

Since 2003, Roche has fostered and expanded collaborations with top medical schools and research institutions across China. By supporting medical education, enhancing school-enterprise partnerships, and encouraging academic innovation, Roche has contributed to nurturing high-quality talent in life sciences and healthcare, fueling industry advancement and driving the realisation of the "Healthy China" vision.

Roche China Education and Research Fund covers three parts:

Roche China Education Fund:
  • Established in 2003, it is the first and longest-standing education scholarship offered by a company in China’s medical industry
  • 20+ years of continuous training, nurturing outstanding talents for China's medical education and research
  • As of January 2025, it has supported more than 2,300 students from 24 universities
Lorem
Roche University Research Fund:
  • Established in 2012, this fund is the first of its kind in China’s medical industry, dedicated to supporting non-profit medical testing institutions and scientific researchers. Its primary goal is to promote the transformation of basic research into clinical practice
  • A jury of over 20 senior industry experts carefully evaluates submissions to ensure fair and rigorous decision-making
  • As of January 2025, the fund has supported 405 researchers from 130 universities
Roche China Visiting Professor Fund:
 
  • Established in 2022, it is the first talent development fund in China’s medical industry dedicated to supporting professors.
  • Aims to build a high-level talent pool for China’s medical and healthcare sectors while establishing a national think tank for public health and health management policy
  • As of January 2025, the fund has supported over 30 high-level professionals in the fields of group medicine and public health